Literature DB >> 25564537

The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.

Rachael Lisa Morton1, Iryna Schlackow2, Borislava Mihaylova2, Natalie Dawn Staplin3, Alastair Gray2, Alan Cass4.   

Abstract

It is unclear whether a social gradient in health outcomes exists for people with moderate-to-severe chronic kidney disease (CKD). We critically review the literature for evidence of social gradients in health and investigate the 'suitability' of statistical analyses in the primary studies. In this equity-focused systematic review among adults with moderate-to-severe CKD, factors of disadvantage included gender, race/ethnicity, religion, education, socio-economic status or social capital, occupation and place of residence. Outcomes included access to healthcare, kidney disease progression, cardiovascular events, all-cause mortality and suitability of analyses. Twenty-four studies in the pre-dialysis population and 34 in the dialysis population representing 8.9 million people from 10 countries were included. In methodologically suitable studies among pre-dialysis patients, a significant social gradient was observed in access to healthcare for those with no health insurance and no home ownership. Low income and no home ownership were associated with higher cardiovascular event rates and higher mortality [HR 1.94, 95% confidence interval (CI) 1.27-2.98; HR 1.28, 95% CI 1.04-1.58], respectively. In methodologically suitable studies among dialysis patients, females, ethnic minorities, those with low education, no health insurance, low occupational level or no home ownership were significantly less likely to access cardiovascular healthcare than their more advantaged dialysis counterparts. Low education level and geographic remoteness were associated with higher cardiovascular event rates and higher mortality (HR 1.54, 95% CI 1.01-2.35; HR 1.21, 95% CI 1.08-1.37), respectively. Socially disadvantaged pre-dialysis and dialysis patients experience poorer access to specialist cardiovascular health services, and higher rates of cardiovascular events and mortality than their more advantaged counterparts.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  causal pathways; chronic kidney disease; inequalities; systematic review

Mesh:

Year:  2015        PMID: 25564537     DOI: 10.1093/ndt/gfu394

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  30 in total

1.  Socioeconomic Position and Incidence of Glomerular Diseases.

Authors:  Mark Canney; Dilshani Induruwage; Anahat Sahota; Cathal McCrory; Michelle A Hladunewich; Jagbir Gill; Sean J Barbour
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 8.237

2.  Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis.

Authors:  Sibei Tao; Xiaoxi Zeng; Jing Liu; Ping Fu
Journal:  Int Urol Nephrol       Date:  2019-01-28       Impact factor: 2.370

3.  Association of insurance status with chronic kidney disease stage at diagnosis in children.

Authors:  Guohua He; Chenglong Li; Shengfeng Wang; Haibo Wang; Jie Ding
Journal:  Pediatr Nephrol       Date:  2022-02-28       Impact factor: 3.651

4.  When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework.

Authors:  J Jull; M Whitehead; M Petticrew; E Kristjansson; D Gough; J Petkovic; J Volmink; C Weijer; M Taljaard; S Edwards; L Mbuagbaw; R Cookson; J McGowan; A Lyddiatt; Y Boyer; L G Cuervo; R Armstrong; H White; M Yoganathan; T Pantoja; B Shea; K Pottie; O Norheim; S Baird; B Robberstad; H Sommerfelt; Y Asada; G Wells; P Tugwell; V Welch
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

5.  Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial.

Authors:  Mohua Basu; Lisa Petgrave-Nelson; Kayla D Smith; Jennie P Perryman; Kevin Clark; Stephen O Pastan; Thomas C Pearson; Christian P Larsen; Sudeshna Paul; Rachel E Patzer
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-26       Impact factor: 8.237

Review 6.  Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.

Authors:  John S Thurlow; Megha Joshi; Guofen Yan; Keith C Norris; Lawrence Y Agodoa; Christina M Yuan; Robert Nee
Journal:  Am J Nephrol       Date:  2021-03-22       Impact factor: 4.605

7.  Understanding healthcare practices in superdiverse neighbourhoods and developing the concept of welfare bricolage: Protocol of a cross-national mixed-methods study.

Authors:  Jenny Phillimore; Hannah Bradby; Michi Knecht; Beatriz Padilla; Tilman Brand; Sin Yi Cheung; Simon Pemberton; Hajo Zeeb
Journal:  BMC Int Health Hum Rights       Date:  2015-06-28

8.  Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease.

Authors:  Wahida Kihal-Talantikite; Cécile Vigneau; Séverine Deguen; Muriel Siebert; Cécile Couchoud; Sahar Bayat
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

9.  GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence.

Authors:  Vivian A Welch; Elie A Akl; Kevin Pottie; Mohammed T Ansari; Matthias Briel; Robin Christensen; Antonio Dans; Leonila Dans; Javier Eslava-Schmalbach; Gordon Guyatt; Monica Hultcrantz; Janet Jull; Srinivasa Vittal Katikireddi; Eddy Lang; Elizabeth Matovinovic; Joerg J Meerpohl; Rachael L Morton; Annhild Mosdol; M Hassan Murad; Jennifer Petkovic; Holger Schünemann; Ravi Sharaf; Bev Shea; Jasvinder A Singh; Ivan Solà; Roger Stanev; Airton Stein; Lehana Thabaneii; Thomy Tonia; Mario Tristan; Sigurd Vitols; Joseph Watine; Peter Tugwell
Journal:  J Clin Epidemiol       Date:  2017-04-04       Impact factor: 6.437

10.  Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.

Authors:  Rachael L Morton; Iryna Schlackow; Natalie Staplin; Alastair Gray; Alan Cass; Richard Haynes; Jonathan Emberson; William Herrington; Martin J Landray; Colin Baigent; Borislava Mihaylova
Journal:  Am J Kidney Dis       Date:  2015-09-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.